Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 2
2017 1
2018 2
2019 3
2020 14
2021 16
2022 11
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease.
Yamanouchi M, Sawa N, Toyama T, Shimizu M, Oshima M, Yoshimura Y, Sugimoto H, Kurihara S, Oba Y, Ikuma D, Mizuno H, Sekine A, Suwabe T, Hoshino J, Ubara Y, Hara S, Furuichi K, Wada T. Yamanouchi M, et al. Among authors: oshima m. Kidney Int Rep. 2023 Nov 10;9(2):323-333. doi: 10.1016/j.ekir.2023.11.004. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344735 Free PMC article.
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial.
Koshino A, Neuen BL, Oshima M, Toyama T, Hara A, Arnott C, Neal B, Jardine M, Badve SV, Mahaffey KW, Pollock C, Hansen MK, Wada T, Heerspink HJL. Koshino A, et al. Among authors: oshima m. Kidney Int Rep. 2023 Dec 1;9(2):347-355. doi: 10.1016/j.ekir.2023.11.024. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344715 Free PMC article.
Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees.
Tokumaru T, Toyama T, Nakade Y, Ogura H, Oshima M, Nakagawa S, Furuichi M, Kitajima S, Sakai N, Shimizu M, Iwata Y, Wada T. Tokumaru T, et al. Among authors: oshima m. Clin Exp Nephrol. 2024 May;28(5):440-446. doi: 10.1007/s10157-023-02450-x. Epub 2024 Feb 10. Clin Exp Nephrol. 2024. PMID: 38340247 Free PMC article. Clinical Trial.
A Japanese Case of COVID-19 Caused by Omicron Strain with Y453F Substitution.
Yamazaki H, Iwata Y, Maekawa A, Azuma T, Shimano Y, Yokoyama T, Nakade J, Tanaka Y, Nakamura Y, Takahashi Y, Zaimoku Y, Oe H, Oshima M, Mori M, Gabata T. Yamazaki H, et al. Among authors: oshima m. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2023 Dec 26;33(1):19-21. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2023. PMID: 38229458
Protective Role of MAVS Signaling for Murine Lipopolysaccharide-Induced Acute Kidney Injury.
Tran TAT, Iwata Y, Hoang LT, Kitajima S, Yoneda-Nakagawa S, Oshima M, Sakai N, Toyama T, Yamamura Y, Yamazaki H, Hara A, Shimizu M, Sako K, Minami T, Yuasa T, Horikoshi K, Hayashi D, Kajikawa S, Wada T. Tran TAT, et al. Among authors: oshima m. Immunohorizons. 2024 Jan 1;8(1):1-18. doi: 10.4049/immunohorizons.2300069. Immunohorizons. 2024. PMID: 38169549 Free PMC article.
Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study.
Oshima M, Toyama T, Nakade Y, Yomogida D, Yuasa T, Horikoshi K, Minami T, Ogura H, Nakagawa S, Miyagawa T, Kitajima S, Hara A, Sakai N, Shimizu M, Mita M, Kinoshita M, Nakada M, Kikuchi M, Iwata Y, Wada T. Oshima M, et al. Clin Ther. 2023 Sep;45(9):889-893. doi: 10.1016/j.clinthera.2023.07.002. Epub 2023 Jul 22. Clin Ther. 2023. PMID: 37487866
Myocardin-related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts.
Yamamura Y, Sakai N, Iwata Y, Lagares D, Hara A, Kitajima S, Toyama T, Miyagawa T, Ogura H, Sato K, Oshima M, Nakagawa S, Tamai A, Horikoshi K, Matsuno T, Yamamoto N, Hayashi D, Toyota Y, Kaikoi D, Shimizu M, Tager AM, Wada T. Yamamura Y, et al. Among authors: oshima m. FASEB J. 2023 Jul;37(7):e23005. doi: 10.1096/fj.202201870R. FASEB J. 2023. PMID: 37289107
Intra-Brain and Plasma Levels of L-Serine Are Associated with Cognitive Status in Patients with Chronic Kidney Disease.
Iwata Y, Nakade Y, Kinoshita M, Sabit H, Nakajima R, Furuichi K, Mita M, Nakane M, Sakai N, Kitajima S, Toyama T, Miyagawa T, Hara A, Shimizu M, Sato K, Oshima M, Nakagawa S, Yamamura Y, Ogura H, Koshino Y, Nakada M, Wada T. Iwata Y, et al. Among authors: oshima m. Kidney Dis (Basel). 2023 Jan 13;9(2):118-129. doi: 10.1159/000527798. eCollection 2023 Apr. Kidney Dis (Basel). 2023. PMID: 37065608 Free PMC article.
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial.
van der Hoek S, Jongs N, Oshima M, Neuen BL, Stevens J, Perkovic V, Levin A, Mahaffey KW, Pollock C, Greene T, Wheeler DC, Jardine MJ, Heerspink HJL. van der Hoek S, et al. Among authors: oshima m. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):748-758. doi: 10.2215/CJN.0000000000000161. Epub 2023 Mar 31. Clin J Am Soc Nephrol. 2023. PMID: 36999981 Clinical Trial.
59 results